VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 2119 · 115th Congress

Therapeutic Fraud Prevention Act of 2017

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

TLD LieuSponsor
177 cosponsors · 177 D
PAD Aguilar EBD Blumenauer SBD Bonamici JBD Brownley YCD Clarke SCD Cohen JCD Chu DCD Cicilline KCD Clark SCD Carbajal DDD DeGette SDD Davis SDD DelBene MDD DeSaulnier VDD Demings EED Engel AED Eshoo EED Esty AED Espaillat RGD Grijalva AGD Green RGD Gallego AHD Hastings BHD Higgins JHD Himes SJD Jackson Lee PJD Jayapal WKD Keating DKD Kildee NLD Lowey BLD Lee JLD Langevin RLD Larsen SLD Lynch CMD Maloney JMD McGovern BMD McCollum GMD Moore DMD Matsui SMD Maloney SMD Moulton JND Nadler END Norton GND Napolitano FPD Pallone BPD Pascrell NPD Pelosi CPD Pingree MPD Pocan SPD Peters JPD Panetta MQD Quigley BRD Rush JRD Rosen JSD Serrano LSD Slaughter JSD Schakowsky ASD Schiff JSD Speier KSD Schrader KSD Sinema ESD Swalwell NTD Tsongas MTD Takano NVD Velázquez DWD Wasserman Schultz PWD Welch BWD Watson Coleman JCD Courtney DHD Heck JHD Huffman JKD Kennedy RKD Krishnamoorthi MLD Lujan Grisham GMD Meng BOD O’Rourke DTD Titus KED Ellison ALD Lowenthal MCD Cartwright SLD Levin CRD Ruppersberger DBD Beyer KCD Castor TDD Deutch BFD Foster LGD Gutiérrez DKD Kilmer JLD Lewis GMD Meeks ASD Smith PTD Tonko TCD Cárdenas PVD Visclosky BSD Scott CCD Crist JBD Beatty ZLD Lofgren BSD Schneider DSD Soto LSD Sánchez KRD Rice AAD Adams TWD Walz KBD Bass DPD Price LRD Roybal-Allard AMD McEachin JGD Gomez RBD Brady MBD Bordallo NBD Barragán GCD Connolly LFD Frankel MKD Kaptur RKD Kihuen BLD Luján TRD Ryan MTD Thompson JDD Delaney RKD Kind RKD Khanna SMD Murphy DND Norcross RRD Ruiz JRD Raskin NTD Torres JVD Vargas JYD Yarmuth ABD Bera ACD Carson JCD Castro PDD DeFazio LDD Doggett MFD Fudge JGD Garamendi SHD Hoyer TOD O’Halleran EPD Perlmutter BSD Sherman JCD Crowley RDD DeLauro DDD Dingell TGD Gabbard JGD Gottheimer CHD Hanabusa HJD Johnson HJD Jeffries CLD Lamb RND Neal ASD Sires CSD Shea-Porter TSD Suozzi BTD Thompson MVD Veasey FVD Vela RKD Kelly CBD Bustos BBD Boyle JCD Correa DED Evans DLD Loebsack ALD Lawson WCD Clay MDD Doyle JLD Larson DPD Payne CRD Richmond BLD Lawrence MCD Capuano ECD Cummings ABD Brown AKD Kuster JCD Costa JMD McNerney MWD Waters JMD Morelle

68 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill prohibits sexual orientation or gender identity conversion therapy from being provided in exchange for monetary compensation.

What it does: CRS summary · Introduced in House · Apr 25, 2017

Therapeutic Fraud Prevention Act of 2017

This bill prohibits sexual orientation or gender identity conversion therapy from being provided in exchange for monetary compensation. It bars advertisements for such therapy that claim to: (1) change an individual's sexual orientation or gender identity, (2) eliminate or reduce sexual or romantic attractions or feelings toward individuals of the same gender, or (3) be harmless or without risk.

Individuals or entities shall not assist or facilitate a conversion therapy if they receive monetary compensation from any source in connection with providing such therapies.

These prohibitions are inapplicable to practices or treatments that do not seek to change sexual orientation or gender identity if they provide: (1) assistance to an individual undergoing a gender transition; or (2) acceptance, support, and understanding of clients or facilitation of clients' coping, social support, and identity exploration and development, including sexual orientation-neutral interventions to prevent or address unlawful conduct or unsafe sexual practices.

The Federal Trade Commission and states are provided authority to enforce against violations.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Therapeutic Fraud Prevention Act of 2017

Latest action (Apr 28, 2017): Referred to the Subcommittee on Digital Commerce and Consumer Protection.

Policy area: Commerce · Origin: House · Introduced: Apr 25, 2017

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.